Ligand validation:5X93

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5X93 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5X93_OLC_A_1210	24%	81%	0.19	0.855	0.23	0.57	-	-	4	0	80%	0.8
5X93_OLC_A_1206	15%	80%	0.199	0.817	0.21	0.61	-	-	0	0	68%	0.68
5X93_OLC_A_1202	9%	53%	0.266	0.759	0.91	0.89	1	1	2	0	100%	1
5X93_OLC_A_1203	9%	50%	0.282	0.769	0.91	1.01	1	1	2	0	100%	1
5X93_OLC_A_1205	5%	54%	0.298	0.701	0.92	0.86	1	1	2	0	100%	1
5X93_OLC_A_1211	4%	52%	0.291	0.676	0.92	0.94	1	1	0	0	100%	1
5X93_OLC_A_1209	4%	55%	0.314	0.697	0.94	0.8	1	1	1	0	100%	1
5X93_OLC_A_1208	3%	52%	0.36	0.715	0.91	0.95	1	1	3	0	100%	1
5X93_OLC_A_1204	2%	55%	0.403	0.686	0.93	0.81	1	1	0	0	100%	1
5X93_OLC_A_1212	1%	50%	0.338	0.567	0.96	0.98	1	2	1	0	100%	1
5X93_OLC_A_1207	1%	50%	0.401	0.602	0.95	0.97	1	2	0	0	100%	1
6K1Q_OLC_A_1209	18%	52%	0.29	0.879	0.93	0.93	1	2	0	0	100%	1
5GLI_OLC_A_1208	12%	54%	0.319	0.846	0.92	0.85	1	1	1	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.